Amneal Pharmaceuticals Inc (AMRX)

7.915 -0.18 (-2.28%) USD  |  NASDAQ  |  Dec 12, 16:00
7.915 0.00 (0.00%) After-Hours: 19:27
More

Amneal Pharmaceuticals Max Drawdown (5Y): 94.77% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for AMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Edwards Lifesciences Corp 54.32%
Eli Lilly and Co 24.12%
KORU Medical Systems Inc 84.30%
Nutriband Inc 95.27%
Eyenovia Inc 98.80%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -0.3177
Beta (5Y) 1.122
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 56.90%
Historical Sharpe Ratio (5Y) 0.2578
Historical Sortino (5Y) 0.4278
Monthly Value at Risk (VaR) 5% (5Y Lookback) 23.42%